Litcius/Paper detail

PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling

Biao Xu, Jingyuan Li, Dehong Xu, Qijie Ran

2022Irish Journal of Medical Science (1971 -)12 citationsDOI

Topics & Concepts

BortezomibViability assayPI3K/AKT/mTOR pathwayProtein kinase BApoptosisChemistryMultiple myelomaCell growthMTT assayCancer researchProteasome inhibitorCell culturePharmacologyMedicineBiologyInternal medicineBiochemistryGeneticsMultiple Myeloma Research and TreatmentsMicrotubule and mitosis dynamicsPI3K/AKT/mTOR signaling in cancer
PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling | Litcius